AKT1 and COVID-19: In conclusion, Naringenin may have an antiviral, anti-inflammatory, and anti-cancer effect by regulating oxidative stress, apoptosis, HIF-1, PI3K-Akt, and VEGF signaling pathways in order to alleviate the clinical symptoms of COVID-19/LUSC patients.